Marvin J Fritzler, PhD, MD
Professor, Cumming School of Medicine
Director, Mitogen Advanced Diagnostics, University of Calgary
Professor Marvin Fritzler received his PhD in 1971 and MD in 1974 from the University of Calgary. He went to The Scripps Research Institute in La Jolla, Californa and then to the University of Colorado as a research fellow under the mentorship of Dr. Eng M. Tan. After a post-doctoral fellowship at the University of Colorado, he joined the University of Calgary in 1978 where he is currently Professor in the Cumming School of Medicine. His clinical and research activity is devoted to biomarker identification and autoantibody testing. From 2001 to 2015, he served as Chair of the Alberta Research and Innovation Authority, a strategic policy advisory board of the Government of Alberta. He has published over 420 peer-reviewed manuscripts and has over 11,000 citations. He has received numerous awards including Canadian Rheumatology Association Scientist of the Year (2003), Master of the American College of Rheumatology (2013), Order of the University of Calgary (2014), and Carl R Jolliff Award for Lifetime Achievement in Clinical and Diagnostic Immunology from the American Association of Clinical Chemistry (2016). He is the Director of Mitogen International Advanced Diagnostics in Calgary, Alberta.
Immunotherapy: Immune Modulation to Cure RA
Ranjeny Thomas, MBBS (WA), MD (WA), FRACP, FAAHMS
Professor of Rheumatology, University of Queensland, Translational Research Institute
Consultant Rheumatologist, Princess Alexandra Hospital
Fellow, Australian Academy of Health and Medical Sciences
Professor Thomas' research seeks to understand autoimmune disease and restoration of immune tolerance. Through this work, she developed and tested the first rheumatoid arthritis vaccine. She has also contributed major insights into how the microbiome is involved in causing spondyloarthropathy leading to the development of disease biomarkers and therapeutic strategies. Ranjeny is founder and a director of the spin-off company, Dendright, which is developing immunotherapy for autoimmune diseases.
Arthritis Care in the Digital Age: The Patient CAN See You Now
Linda Li, BSc(PT), MSc, PhD
Harold Robinson Chair / Arthritis Society Chair in Arthritic Diseases
Associate Professor, Department of Physical Therapy, University of British Columbia
Professor Li is Harold Robinson / Arthritis Society Chair at the Department of Physical Therapy, University of British Columbia, and Senior Research Scientist at Arthritis Research Canada. She holds a Canada Research Chair in Patient-oriented Knowledge Translation.
Professor Li’s research focuses on understanding the help-seeking experience of people with arthritis, evaluating the use of models of care, and more recently, studying the experience and benefits of patient engagement in research. She collaborates with digital media experts to create and evaluate online tools, such as patient decision aids for promoting shared-decision making and interactive programs to support an active lifestyle. In 2015, Professor Li was awarded the Distinguished Scholar Award by the Association of Rheumatology Health Professionals (a division of American College of Rheumatology) for her achievements in scholarly activities pertinent to arthritis and rheumatic diseases.